RXSIGHT, INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • July 9th, 2021 • RxSight, Inc. • Ophthalmic goods • Delaware
This Indemnification Agreement (this “Agreement”) is dated as of and is between RxSight, Inc., a Delaware corporation (the “Company”), and [insert name of indemnitee] (“Indemnitee”).
LOAN AND SECURITY AGREEMENTLoan and Security Agreement • July 9th, 2021 • RxSight, Inc. • Ophthalmic goods
THIS LOAN AND SECURITY AGREEMENT (as the same may from time to time be amended, modified, supplemented or restated, this “Agreement”) dated as of October 29, 2020 (the “Effective Date”) among OXFORD FINANCE LLC, a Delaware limited liability company with an office located at 133 North Fairfax Street, Alexandria, Virginia 22314 (“Oxford”), as collateral agent (in such capacity, “Collateral Agent”), the Lenders listed on Schedule 1.1 hereof or otherwise a party hereto from time to time including Oxford in its capacity as a Lender (each a “Lender” and collectively, the “Lenders”), and RXSIGHT, INC., a California corporation with offices located at 100 Columbia, Aliso Viejo, CA 92656 (“Borrower”), provides the terms on which the Lenders shall lend to Borrower and Borrower shall repay the Lenders. The parties agree as follows:
RXSIGHT, INC. CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • July 9th, 2021 • RxSight, Inc. • Ophthalmic goods • California
This Change in Control Severance Agreement (the “Agreement”) is made between RxSight, Inc. (the “Company”) and Shelley B. Thunen (the “Executive”), effective as of July 16, 2021 (the “Effective Date”).
July 8, 2021 Eric J. Weinberg c/o RxSight, Inc. Aliso Viejo, CA 92656 Re: Confirmatory Employment Letter Dear Eric:Letter Agreement • July 9th, 2021 • RxSight, Inc. • Ophthalmic goods
This letter agreement (the “Agreement”) is entered into between Eric J. Weinberg (“you”) and RxSight, Inc. (the “Company” or “we”). This Agreement is effective as of July 16, 2021 . The purpose of this Agreement is to confirm the terms and conditions of your employment.
RXSIGHT, INC. CONSULTING AGREEMENTConsulting Agreement • July 9th, 2021 • RxSight, Inc. • Ophthalmic goods • California
This Consulting Agreement (the “Agreement”) is made by and between RxSight, Inc. (the “Company”), and Daniel M. Schwartz, MD (the “Consultant”), in the state of California, effective January 1st, 2019.
LEASE AGREEMENT (INDUSTRIAL/COMMERCIAL SINGLE-TENANT)Lease Agreement • July 9th, 2021 • RxSight, Inc. • Ophthalmic goods • California
LICENSE AND MAINTENANCE AGREEMENTLicense and Maintenance Agreement • July 9th, 2021 • RxSight, Inc. • Ophthalmic goods • California
Calhoun Vision, Inc. having its principal place of business at 171 North Altadena Drive, Suite 201, Pasadena, CA 91107 (hereinafter “Customer”),
CLOUD SERVICES AGREEMENTCloud Services Agreement • July 9th, 2021 • RxSight, Inc. • Ophthalmic goods • California
QAD Inc., having its principal place of business at 100 Innovation Place, CA 93108 Santa Barbara, United States (hereinafter “Vendor”), and
COMMERCIAL LEASE AGREEMENT BETWEEN ACCURIDE INTERNATIONAL, INC. a California corporation as Landlord and Calhoun Vision, Inc. a California corporation as Tenant Dated: October 27, 2015Commercial Lease Agreement • July 9th, 2021 • RxSight, Inc. • Ophthalmic goods • California
This Commercial Lease Agreement (hereinafter called this “Lease”) is made this 31st day of August, 2015 between ACCURIDE INTERNATIONAL, INC., a California corporation (hereinafter called “Landlord”) and Calhoun Vision, Inc. (“Tenant”).
RXSIGHT, INC. NINTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT FEBRUARY 24, 2017Investors’ Rights Agreement • July 9th, 2021 • RxSight, Inc. • Ophthalmic goods • California
This NINTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of February 24, 2017 (the “Effective Date”), by and among RxSight, Inc., a California corporation (the “Company”), those holders of the Company’s Series A Preferred Stock, $0.001 par value per share (“Series A Preferred”) and of the Company’s Common Stock, $0.001 par value per share (“Common Stock”) listed on Exhibit A hereto (the “Series A Investors”), those holders of the Company’s Series B Preferred Stock, par value $0.001 per share (“Series B Preferred”) listed on Exhibit B hereto (the “Series B Investors”), those holders of the Company’s Series C Preferred Stock, par value $0.001 per share (“Series C Preferred”) listed on Exhibit C hereto (the “Series C Investors”), those holders of the Company’s Series D Preferred Stock, par value $0.001 per share (“Series D Preferred”) listed on Exhibit D hereto (the “Series D Investors”), those holders of the Company’s Series E Preferred S
LICENCE AGREEMENTLicence Agreement • July 9th, 2021 • RxSight, Inc. • Ophthalmic goods • California
THIS AGREEMENT is effective as of the 28th day of July, 2015 (the “Effective Date”), between the CALIFORNIA INSTITUTE OF TECHNOLOGY (“Caltech”), a not-for-profit corporation duly organized and existing under the laws of the State of California with an address at 1200 East California Boulevard, MC 6-32, Pasadena, California 91125 and Calboun Vision, Inc. (“Licensee”), a California corporation having a place of business at 2555 E. Colorado Blvd., Pasadena, CA 91107 (the “Parties”).
EXCLUSIVE LICENSE AGREEMENT between THE REGENTS OF THE UNIVERSITY OF CALIFORNIA and CALHOUN VISION, INC. for SILICONE INTRAOCULAR LENSES EMBEDDED WITH PHOTOSENSITIVE COMPOSITIONS (SF99-076) and METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE CLOSURE...Exclusive License Agreement • July 9th, 2021 • RxSight, Inc. • Ophthalmic goods • California
This license agreement (the “Agreement”) is made effective March 1, 2000 (the “Effective Date”) between THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, a California corporation having its statewide administrative offices at 1111 Franklin Street, Oakland, California 94607-5200, (“The Regents”), and acting through its Office of Technology Management, University of California San Francisco, 1294 Ninth Avenue - Suite 1, Box 1209, San Francisco, CA 94143-1209 (“UCSF”), and CALHOUN VISION INC., a California corporation having a principal place of business at [***], (the “Licensee”).
